Kohei Otsubo

1.8k total citations
52 papers, 1.1k citations indexed

About

Kohei Otsubo is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Kohei Otsubo has authored 52 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 24 papers in Pulmonary and Respiratory Medicine and 9 papers in Molecular Biology. Recurrent topics in Kohei Otsubo's work include Lung Cancer Treatments and Mutations (15 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Lung Cancer Research Studies (9 papers). Kohei Otsubo is often cited by papers focused on Lung Cancer Treatments and Mutations (15 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Lung Cancer Research Studies (9 papers). Kohei Otsubo collaborates with scholars based in Japan, Canada and Italy. Kohei Otsubo's co-authors include Yoichi Nakanishi, Ichiro Ieiri, Kentaro Tanaka, Eiji Iwama, Yasuto Yoneshima, Taishi Harada, Isamu Okamoto, Hiroyuki Kusuhara, Kiyoshi Maeda and Tomoko Watanabe and has published in prestigious journals such as Oncogene, Annals of Oncology and International Journal of Cancer.

In The Last Decade

Kohei Otsubo

49 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kohei Otsubo Japan 19 610 429 265 167 144 52 1.1k
Jason R. Manro United States 14 556 0.9× 158 0.4× 420 1.6× 323 1.9× 244 1.7× 28 1.3k
Alice A. Gibson United States 23 790 1.3× 158 0.4× 391 1.5× 213 1.3× 261 1.8× 46 1.4k
Mohamed Elmeliegy United States 16 583 1.0× 289 0.7× 304 1.1× 86 0.5× 90 0.6× 52 944
Anke Geick Germany 10 674 1.1× 179 0.4× 407 1.5× 481 2.9× 253 1.8× 11 1.3k
Craig Eagle United States 13 536 0.9× 239 0.6× 254 1.0× 89 0.5× 51 0.4× 26 1.6k
Jason A. Sprowl United States 19 747 1.2× 108 0.3× 315 1.2× 151 0.9× 295 2.0× 34 1.2k
Peng Duan China 17 332 0.5× 158 0.4× 466 1.8× 102 0.6× 97 0.7× 43 982
Emiko Sugiyama Japan 15 395 0.6× 125 0.3× 257 1.0× 210 1.3× 46 0.3× 32 1.0k
Dagmar Busse Germany 12 584 1.0× 159 0.4× 316 1.2× 300 1.8× 184 1.3× 22 1.0k
M Hanano Japan 23 571 0.9× 159 0.4× 300 1.1× 226 1.4× 325 2.3× 68 1.6k

Countries citing papers authored by Kohei Otsubo

Since Specialization
Citations

This map shows the geographic impact of Kohei Otsubo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kohei Otsubo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kohei Otsubo more than expected).

Fields of papers citing papers by Kohei Otsubo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kohei Otsubo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kohei Otsubo. The network helps show where Kohei Otsubo may publish in the future.

Co-authorship network of co-authors of Kohei Otsubo

This figure shows the co-authorship network connecting the top 25 collaborators of Kohei Otsubo. A scholar is included among the top collaborators of Kohei Otsubo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kohei Otsubo. Kohei Otsubo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Otsubo, Kohei, et al.. (2025). Remarkable response to crizotinib in a patient with advanced lung adenocarcinoma harboring the MPRIP-ROS1 fusion gene: A case report. Respiratory Medicine Case Reports. 56. 102243–102243.
3.
4.
Hikasa, Hiroki, Kohichi Kawahara, Kohei Otsubo, et al.. (2024). A highly sensitive reporter system to monitor endogenous YAP1/TAZ activity and its application in various human cells. Cancer Science. 115(10). 3370–3383. 1 indexed citations
5.
Yamamoto, Yoshihiro, Kohei Otsubo, Yoshimasa Shiraishi, et al.. (2024). Tracheomediastinal fistula induced by concurrent chemoradiotherapy in small cell lung cancer: A case report and literature review. Thoracic Cancer. 15(13). 1106–1111. 1 indexed citations
6.
Vierhout, Megan, Kohei Otsubo, Kazuya Tsubouchi, et al.. (2023). Therapeutic strategies to target connective tissue growth factor in fibrotic lung diseases. Pharmacology & Therapeutics. 253. 108578–108578. 23 indexed citations
7.
Takada, Kazuki, Sebastiano Buti, Melissa Bersanelli, et al.. (2022). Antibiotic-dependent effect of probiotics in patients with non-small cell lung cancer treated with PD-1 checkpoint blockade. European Journal of Cancer. 172. 199–208. 13 indexed citations
8.
9.
Ito, Kentaro, Shinya Sakata, Kohei Otsubo, et al.. (2021). MO4-5 A multicenter retrospective study of Oncomine Dx Target Test multi-CDx system for genetic profiling of NSCLC: WJOG13019L. Annals of Oncology. 32. S297–S297. 1 indexed citations
10.
Yoneshima, Yasuto, Keiichi Ota, Kohei Otsubo, et al.. (2019). Multiclonality and Radiosensitivity of Granulocyte-colony Stimulating Factor-Producing Lung Adenocarcinoma Positive for an Activating EGFR Mutation. Clinical Lung Cancer. 21(1). e21–e24. 4 indexed citations
11.
Yoneshima, Yasuto, Kayo Ijichi, Keiichi Ota, et al.. (2018). PD-L1 expression in lung adenocarcinoma harboring EGFR mutations or ALK rearrangements. Lung Cancer. 118. 36–40. 76 indexed citations
12.
13.
Sakata, Shinya, Sho Saeki, Isamu Okamoto, et al.. (2016). Phase II trial of weekly nab-paclitaxel for previously treated advanced non–small cell lung cancer: Kumamoto thoracic oncology study group (KTOSG) trial 1301. Lung Cancer. 99. 41–45. 22 indexed citations
14.
Otsubo, Kohei, Yasuhiro Okabe, Atsushi Sugitani, et al.. (2009). Evaluation of inosin-5â²-monophosphate dehydrogenase activity during maintenance therapy with tacrolimus. Journal of Clinical Pharmacy and Therapeutics. 35(1). 79–85. 7 indexed citations
15.
Teshima, Daisuke, Kohei Otsubo, Nobuki Kitagawa, et al.. (2008). Estimation of the area under the curve for mycophenolic acid in adult renal transplant patients with concomitant tacrolimus using a limited sampling strategy. Journal of Clinical Pharmacy and Therapeutics. 33(2). 159–163. 15 indexed citations
16.
Maeda, Kiyoshi, Ichiro Ieiri, Kiyomi Yasuda, et al.. (2006). Effects of organic anion transporting polypeptide 1B1 haplotype on pharmacokinetics of pravastatin, valsartan, and temocapril. Clinical Pharmacology & Therapeutics. 79(5). 427–439. 161 indexed citations
17.
Teshima, Daisuke, et al.. (2003). High-performance liquid chromatographic method for mycophenolic acid and its glucuronide in serum and urine. Journal of Clinical Pharmacy and Therapeutics. 28(1). 17–22. 18 indexed citations
18.
Ieiri, Ichiro, Yui Kishimoto, Hideaki Okochi, et al.. (2001). Comparison of the kinetic disposition of and serum gastrin change by lansoprazole versus rabeprazole during an 8-day dosing scheme in relation to CYP2C19 polymorphism. European Journal of Clinical Pharmacology. 57(6-7). 485–492. 56 indexed citations
19.
Mamiya, Kohsuke, Eiji Yukawa, Ichiro Ieiri, et al.. (2000). CYP2C19 polymorphism effect on phenobarbitone. European Journal of Clinical Pharmacology. 55(11-12). 821–825. 57 indexed citations
20.
Nagasaki, Koichi, Kohei Otsubo, Naofumi Kajimura, et al.. (1996). Circulating Parathyroid Hormone-related Protein (109-141) in Malignancy-associated Hypercalcemia. Japanese Journal of Clinical Oncology. 26(1). 6–11. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jason R. Manro Breakdown of academic impact, for papers by Alice A. Gibson Breakdown of academic impact, for papers by Mohamed Elmeliegy Breakdown of academic impact, for papers by Anke Geick Breakdown of academic impact, for papers by Craig Eagle Breakdown of academic impact, for papers by Jason A. Sprowl Breakdown of academic impact, for papers by Peng Duan Breakdown of academic impact, for papers by Emiko Sugiyama Breakdown of academic impact, for papers by Dagmar Busse Breakdown of academic impact, for papers by M Hanano
Rankless by CCL
2026